Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gamil Sayed Gamil Zeedan has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Application and Optimization of Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Rapid SARS-CoV-2 Detection in Humans and Animals

    by Gamil Sg Zeedan, Abeer M Abdalhamed, Amel M. Naguib, Saied I. Shalaby, Mona A.M. Awad, Mervat I. Abd El Moniem

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) requires quick and dependable diagnostic solutions. Our study aimed to optimize the rapid detection of SARS-CoV-2 using the reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay and to compare its performance with the reverse transcription real-time TaqMan quantitative polymerase chain reaction (RT-qPCR) of RNA extraction protocols. Nasopharyngeal swabs (NPS), oropharyngeal swabs (OPS), mixed nasopharyngeal and saliva samples, and sputum samples from individuals with or without COVID-19 symptoms (outpatient n = 180, inpatient n = 50) were collected and stored at -80 °C. These samples were tested using RT-qPCR, RT-LAMP, and RT-PCR for comparison. Additionally, animal samples were tested, including cattle (n = 20), buffaloes (n = 10), sheep (n = 25), goats (n = 30), horses (n = 5), donkeys (n = 5), mules (n = 3), camels (n = 5), dogs (n = 10), cats (n = 5), and rabbits (n = 6). The detection rates of RT-qPCR were 7.3 ± 0.56, 8.0 ± 0.98, and 5.0 ± 0.56 for nasopharyngeal swabs (NPS), oropharyngeal swabs (OPS), and mixed nasopharyngeal and saliva samples mixed with sputum samples from outpatients (n = 180), respectively. For inpatients (n = 50), the means and SD were 43 ± 0.264, 43 ± 0.245, and 26 ± 0.376, respectively. The sensitivity of RT-LAMP was comparable to RT-qPCR, with 88.9% for outpatients and 99.4% for inpatients. Both assays demonstrated 100% specificity in both groups. The findings demonstrated the direct RT-qPCR assay, both with and without RNA extraction, produced positive results

  • Open Access

    Molecular detection of lumpy skin disease virus in naturally infected cattle and buffaloes: unveiling the role of tick vectors in disease spread

    by Gamil S. G. Zeedan, Abeer M. Abdalhamed, Ahmad M. Allam, Sobhy Abdel-Shafy

    Lumpy skin disease (LSD) is a viral disease that affects cattle and buffaloes in Egypt, causing considerable economic losses in the animal sector. This study aimed to investigate the recent outbreak of LSDV in cattle and buffaloes and evaluate the potential role of the hard tick Rhipicephalus annulatus in their transmission through isolation and molecular characterization by multiplex PCR (mPCR) and real-time quantitative PCR (rt-qPCR) assays. A total of 50 skin biopsies (cattle n = 30, buffaloes n = 20), 110 nasal swabs (cattle n = 76, buffaloes n = 44), and 129 blood samples (cattle n = 84, buffaloes n = 45) were collected. In addition, 145 hard ticks of different stages were collected from cattle and buffaloes of different breeds and ages in different governorates in Egypt from November 2021 to June 2022. Multiplex PCR and real-time quantitative PCR (rt-qPCR) assays based on SYBR Green and targets (P32, VP32, G protein, and viral fusion protein) were used. We identified positive results in 17 out of 30 cattle skin biopsies (56.6%), 1 out of 7 buffalo skin scabs (14.3%), and 5 out of 45 buffalo blood samples (11.11%) using mPCR and RT-qPCR methods. We successfully isolated LSDV from hard ticks and cattle infested with ticks and exhibited characteristic signs of LSD on the chorioallantois membrane (CAM) of specific pathogen-free embryonated chicken eggs (SPF-ECE). The isolates were confirmed by multiplex PCR and RT-qPCR. The cyclic threshold (Ct) with correlation-slandered curve values of rt-qPCR ranging from 10.2 to 36.5 showed the amount of LSDV-DNA in different samples. The study's findings demonstrated the widespread circulation of LSDV in both cattle and buffaloes in Egypt and provided strong evidence that hard ticks R. annulatus play a role in the transmission of LSDV in susceptible animals.


  • Open Access

    Antiviral Plant Extracts: A Treasure for Treating Viral Diseases

    by Gamil S.G. Zeedan, Abeer M. Abdalhamed

    Viral infections remain a challenge in human and veterinary medicine due to factors such as viral mutations, new viruses, toxic effects, disease severity, intracellular viability, high costs, and limited availability of antiviral drugs. Despite advancements in immunization and antiviral drugs, there is a need for new and more effective antiviral compounds. Plants produce secondary metabolites that have shown antiviral activity, such as alkaloids, flavonoids, and essential oils. Advanced analytical techniques like HPLC, GC-MS, and NMR spectroscopy are used to identify and characterize these bioactive compounds. Flavonoids, terpenoids, lignans, sulphides, polyphenolics, coumarins, and saponins are among the groups of bioactive compounds found in plants that have demonstrated antiviral activity against viruses like HIV, influenza, herpes simplex, and hepatitis. Screening plant extracts and isolating active compounds allow scientists to identify potential new antiviral drugs. In vitro and in vivo studies have shown significant antiviral activity of plant extracts and their bioactive compounds. However, further research is needed to ensure safety, investigate drug interactions, and explore combination therapies with other natural products. The use of advanced analytical techniques helps identify and characterize bioactive compounds that target different stages of the viral life cycle. Examples of plant extracts and compounds with antiviral activity against specific viruses are mentioned, including SARS-CoV-2 and various veterinary viruses. The abstract emphasizes the ongoing research on natural sources, particularly plants, for the discovery of new and effective antiviral compounds, while highlighting the need for extensive studies on safety, drug interactions, and combination therapies.


  • Strategies for Prevention and Control of Multidrug-resistant Bacteria in Ruminants

    by Gamil Sayed Gamil Zeedan, Abeer Mostafa Abdalhamed, Alaa Abdelmoneam Ghazy

    Antibiotics are no longer effective in treating bacterial infections due to antimicrobial drug resistance. Therefore, various alternative strategies have been developed to combat multidrug-resistant (MDR) bacteria. The current review article aimed to shed light on strategies to prevent and control MDR bacteria in ruminants. Due to the development of new resistant bacteria, there is a need for effective treatments and prevention protocols in livestock and humans. With growing antibiotic-resistant organisms, a few antimicrobial medicines will be available to treat the infection when no new drugs are developed. This highlights the importance of looking for other strategies for combating antibiotic-resistant bacteria. In this regard, alternative strategies have been proposed to minimize antimicrobial drug overuse in ruminants. These alternative procedures include alternatives for growth promotion (such as in-feed enzymes, probiotics, prebiotics, synbiotics, and antimicrobial peptides), alternatives for disease prevention (such as vaccines, immune modulators, chicken egg yolk antibodies, farm management, and biosecurity), and alternatives for disease treatment such as plant extracts and phage-therapy to antibiotics. These alternative methods should be safe‎ and efficient without inducing microbial resistance.


  • An Overview of Adenovirus Vector-based Vaccines against SARS-CoV-2

    by Gamil S. G. Zeedan, Abeer M. Abdalhamed, Amel M. Naguib, Said I. A. Shalaby, Mona A. M. Awad, Mervat I. Abd El Moniem

    Adenovirus vectors have been employed to develop a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for curtailing the Covid-19 pandemic spreading. Many different viral vectors have been mainly targeting the SARS-CoV-2 spike (S) protein as an antigen. Spike (S) protein is comprised of S1 and S2 subunits, in which the receptor-binding domain (RBD) of S1 is responsible for recognizing and engaging with its host cellular receptor protein angiotensin-converting enzyme 2 (ACE2), S2 accounts for membrane fusion of virus and host cell. Chimpanzee adenovirus was also used as a vector vaccine for SARS-CoV-2 (ChAdSARS-CoV-2-S) by intramuscular injection, and intranasal administration has been tested. Adenovirus vector-based vaccines are the most advanced, with several vaccines receiving Emergency Use Authorization (EUA). It was shown that rhesus macaques were protected from SARS-CoV-2 challenge after a month of being vaccinated with ChAd-SARS-CoV-2-S. A single intranasal or two intramuscular ChAd-SARSCoV-2-S vaccines could induce humoral antibodies and T cell responses to protect the upper and lower respiratory tract against SARS-CoV-2. As the effectiveness was demonstrated in non-human primates, ChAd-SARS-CoV-2-Sa potential option for preventing SARS-CoV-2 infection in humans. However, detecting novel more transmissible and pathogenic SARS-CoV-2 variants added concerns about the vaccine efficacy and needs monitoring. Moreover, the cause of recently documented rare cases of vaccine indicated immune thrombotic thrombocytopenia. This review article provided details for the adenovirus vector vaccine for SARS-CoV-2 in humans and tried to provide solutions to the adenovirus vector hemagglutinin issue.

  • Open Access

    Detection of Methicillin-Resistant Staphylococcus aureus in Clinical and Subclinical Mastitis in Ruminants and Studying the Effect of Novel Green Synthetized Nanoparticles as One of the Alternative Treatments

    by Abeer Mostafa Abdalhamed, Gamil Sayed Gamil Zeedan, Amany Ahmed Arafa, Eman Shafeek Ibrahim, Doaa Sedky, Amani Abdel Nabey Hafez

    Mastitis is an important disease in dairy animals worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of clinical and subclinical intramammary infections. In the current study, we isolated bacteria from 150 mastitic milk samples. Multiplex PCR was used to detect the methicillin resistance genes in S. aureus to detect the occurrence of MRSA isolates. Green synthesized titanium dioxide nanoparticles (TiO2 NPs) using aqueous leaf extracts of Artemisia herb Alba (A. herb Alba TiO2 NPs). The antibacterial efficacy of these nanoparticles was evaluated (in vitro and in vivo) against collected MRSA isolates using the disc diffusion method and SPF rats. Out of 150 mastitic milk samples, the frequency of S. aureus was 38 (25.3), that of E. coli was 45 (30), that of Klebsiella spp. Was 7 (4.7), and that of Streptococcus spp. Was 11 (7.3). Among 38 positive isolates of S. aureus, MRSA was 16 (42.1) by antimicrobial sensitivity testing (AST) and 14 (38.8) by multiplex PCR. The MRSA isolates were shown to have 100 resistance to penicillin and methicillin, 87.5 resistance to gentamicin, 50 resistance to cefoxitin and amoxicillin, and 75 resistance to ampicillin and ampicillin/sublactam with low resistance against erythromycin, ciprofloxacin, tetracycline, and levofloxacin by AST, respectively. A. herb Alba TiO2 NP formation was observed by changing the colour from white to dark green. The UV spectrum revealed absorbance peaks at 240250nm, and their sizes ranged from 4266nm and 11 to 45nm by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). A. herb Alba TiO2 NP suspensions were evaluated against MRSA, with the highest zone of inhibition (43±0.45mm) at a concentration of 40μg/ml. Hematological parameters and histological examination after oral administration of 20mg/kg of A. herb Alba TiO2 NPs indicated that A. herb Alba TiO2 NPs can be used as a new antimicrobial against resistant bacteria (MRSA) with consideration of the dose and methods of synthesis of plant-based compounds.


  • Development of gold nanoparticles-lateral flow test as a novel field diagnostic assay for detecting foot-and-mouth disease and lumpy skin disease viruses

    by Abeer Mostafa Abdalhamed, Soad Mohammed Naser, Ayman Hamady Mohamed, Gamil Sayed Gamil Zeedan

    Background and Objectives: Rapid diagnosis is a cornerstone for controlling and preventing viral disease outbreaks. The present study is aimed to develop a rapid field diagnostic test based on gold nanoparticles for the detection of lumpy skin diseases (LSD), and foot and mouth diseases (FMD) in animals with high sensitivity and specificity. Materials and Methods: FMD and LSD vaccines were used as a source of viruses' antigens for preparing monoclonal anti- bodies and conjugated with gold nanoparticles that characterized using various techniques such as UV-visible spectrometry, and transmission electron microscopy (TEM). Monoclonal antibodies (mAbs) for each serotype produced in experimental rats and used to capture antibodies for FMDV and /or LSDV. ELISA was used to screen 469 milk samples and 1165 serum samples from naturally infected cattle, buffaloes, sheep, and goats for validation of the lateral flow test (LFT). LSDV DNA was extracted from 117 blood and skin biopsy samples collected from naturally infected cattle during the 2019 outbreak. Results: The specificity and sensitivity of GNP-LFT were evaluated and compared to Ag-ELISA, Western blot tests (WB), and PCR. A total of 95 FMDV positives out of 469 (20.25%) milk samples and 268 FMDV positives out of 1165 (23.3%) serum samples from natural infected cattle, buffaloes, sheep, and goats examined by ELISA to valid GNPS-LFT Viral LSDV DNA was detected in 60/117 (51.5%) and 31/60 (52.9%). While the GNPS-LFT assay results were 49/117 (41.9%) and 29/60 (48.3%) blood and skin biopsy samples, respectively. The diagnostic sensitivity and specificity of the GNP-LFT test were 72% and 82%, respectively. All vesicular fluid and epithelium samples collected from infected animals were identified as positive by the GNP- LFT and Ag-ELISA. Ag-ELISA, on the other hand, was 90% and 100%. While the developed GNP- LFT used LSDV polyclonal antibodies were similar to ELISA and IgG-WB with a sensitivity of 72.8% and a specificity of 88.8%, respectively. Conclusion: The GNPS-LFT is a novel immunoassay based on mono or polyclonal antibodies conjugated with gold nanopar- ticles that provides an accurate, rapid, specific, and sensitive tool for field rapid diagnosis of FMDV and LSDV.


  • Open Access

    Rapid diagnosis of Toxoplasma gondii using loop-mediated isothermal amplification assay in camels and small ruminants

    by Gamil S. G. Zeedan, Abeer M. Abdalhamed, Raafat M. Shaapan, Amira H. El-Namaky

    Background: This study was conducted to detect the presence of T. gondii in milk and blood samples using three different assays: enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), and loop-mediated isothermal amplification assay (LAMP). Whole blood, serum, and milk samples were collected from goats (n = 156), sheep (n = 261), and camels (n = 108) in different governorates in Egypt from December 2019 to February 2021 and screened by ELISA for anti-Toxoplasma IgG antibodies before DNA extraction. The target T. gondii DNA gene was detected and evaluated using the LAMP assay compared to PCR. Results: T. gondii antibodies were found in milk and serum samples at the rates of (29.26%) and (36.58%) in camels, (34.18%) and (35.89%) in sheep, and (33.7%) and (36.36%) in goats, respectively. Similar to PCR, the percentages of LAMP tests for the detection of the T. gondii DNA gene in milk and blood samples of camels, sheep, and goats were (4.8, 14.63), (6.83, 7.69), and (7.79, 9.09), respectively. LAMP's sensitivity for detecting T. gondii in milk and blood samples, which was identical to that of PCR, was 100%. Conclusions: The findings clearly demonstrated that there were no variations in T. gondii detection capabilities in milk and blood samples from various animals using both PCR and LAMP tests. It provides a quick, precise, and sensitive method of detecting T. gondii in a variety of samples that may be used both in the field and in laboratory diagnosis.


  • Open Access

    Therapeutic effect of biosynthetic gold nanoparticles on multidrug-resistant Escherichia coli and Salmonella species isolated from ruminants

    by Abeer M. Abdalhamed, Alaa A. Ghazy, Eman S. Ibrahim, Amany A. Arafa, Gamil S. G. Zeedan

    Background and Aim: Multidrug-resistant (MDR) pathogenic microorganisms have become a global problem in ruminants as a result of the intensive use of antibiotics, causing the development of resistance among gut microbiota. The antibiotic-resistant microorganisms can be transferred from diseased animals to humans. This study aimed to determine the prevalence of MDR Escherichia coli and Salmonella spp. isolated from cattle, buffaloes, sheep, and goats suffering from respiratory signs, diarrhea, and mastitis and to screen the antibiotic sensitivity of selected isolated bacteria. It also detected antibiotic-resistance genes by polymerase chain reaction (PCR), produced green gold nanoparticles (AuNPs) using plant extracts (Artemisia herba-alba and Morus alba), and evaluated the antimicrobial activities of these biosynthesized nanoparticles on selected pathogens (E. coli and Salmonella spp.). Materials and Methods: MDR E. coli and Salmonella spp. were investigated using fecal samples (n=408), nasal swabs (n=358), and milk samples (n=227) of cattle, buffaloes, sheep, and goats with or without clinical signs, including respiratory manifestations, pneumonia, diarrhea, and mastitis, from different governorates in Egypt. E. coli and Salmonella spp. were isolated and identified on selective media, which were confirmed by biochemical reactions and PCR. Antimicrobial susceptibility testing against 10 commonly used antibiotics was performed using the Kirby-Bauer disk diffusion method. Antibiotic resistance genes blaTEM, blaSHV, blaOXA, and blaCTX-M were detected by PCR. The antibacterial effect of the biosynthesized AuNPs was evaluated by MIC and well diffusion assay. The biosynthesized AuNPs were also characterized by ultraviolet-visible spectrophotometry and transmission electron microscopy (TEM). Results: Among all fecal samples, the prevalence of E. coli was 18.4% (183/993) and that of Salmonella spp. was 16.7% (66/408), as determined by cultural and molecular tests. All isolates of E. coli and Salmonella spp. were 100% resistant to ampicillin (AM) and amoxicillin and highly resistant to cefoxitin and AM-sulbactam. The total rate of resistance genes in E. coli was 61.2% (112/183), while that in Salmonella was 63.6% (42/66) for pathogens isolated from ruminants with respiratory manifestations, pneumonia, diarrhea, and mastitis. Among the resistance genes, blaTEM had the highest prevalence rate in E. coli (25.9%, 21/81) while blaSHV had the lowest (9.8%, 8/81) in fecal swabs. AuNPs were successfully synthesized using aqueous leaf extract of A. herba-alba and M. alba as bioreducing agents. TEM analysis showed particle size of 10-42 nm for A. herba-alba and M. alba AuNPs. The biosynthesized AuNPs showed antibacterial activity against MDR E. coli and Salmonella spp. Conclusion: Rapid and accurate diagnostic methods are the cornerstone for effective treatment to reduce the risk of antimicrobial-resistant pathogenic microorganisms. This is particularly important for overcoming the increasing rate of MDR in ruminants with respiratory manifestations, pneumonia, diarrhea, and mastitis. This can be complemented by the development of AuNPs synthesized in an environmentally friendly manner AuNPs using natural plant extracts for the treatment of antibiotic-resistant microorganisms.